Volume 10, Issue 4 pp. 689-692

Retrograde Filling of a Thoracic Spinal Artery During Transforaminal Injection

Way Yin MD

Way Yin MD

Bellingham Spine Pain Specialists, PS, Bellingham, WA;

Department of Anesthesiology, University of Washington School of Medicine, Seattle, WA, USA;

Search for more papers by this author
Nikolai Bogduk MD, PhD, DSc

Nikolai Bogduk MD, PhD, DSc

University of Newcastle, Newcastle Bone and Joint Institute, Royal Newcastle Centre, Newcastel, New South Wales, Australia

Search for more papers by this author
First published: 05 June 2009
Citations: 1
Way Yin, MD, Bellingham Spine Pain Specialists, PS, 2075 Barkley Blvd., Suite 110, Bellingham Washington 98226, USA. Tel: 360-527-8111; Fax: 360-527-8115; E-mail: [email protected].

ABSTRACT

Introduction. Transforaminal injection of steroids has been associated with infrequent but devastating neurological complications and death. Direct injection of particulate steroids into the vertebral artery or medullary arteries is the leading theory in the majority of these complications. Practice guidelines have been published to minimize the likelihood of directly encountering vulnerable arterial structures. However, retrograde flow into a vertebral or medullary artery has not been considered in the literature.

Case. This case demonstrates retrograde flow into a common arterial trunk with subsequent antegrade flow of intravenous contrast into a thoracic spinal artery during thoracic transforaminal injection.

Discussion. Antegrade flow of particulate steroids through direct cannulation of a vertebral or medullary artery has been advocated as one explanation for complications involving brain or spinal cord infarction. The possibility of retrograde flow into a common arterial trunk with subsequent antegrade flow into vulnerable arteries should also be considered as a possible mechanism by which embolic spinal cord or brain injury may occur.

Conclusion. Retrograde flow into medullary or vertebral arteries without direct cannulation can occur, and provides an alternative mechanism of potential injury to the spinal cord or brain during transforaminal injections.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.